Taking the above findings together, we speculate that in an early phase of obesity, AT2 receptor-mediated signaling pathways play a major role counteracting the effects of Ang II–mediated vasoconstriction as a consequence of the increased plasma levels of this peptide and the decreased levels of Ang-(1–7). The gene discussed is AGTR2; the disease is Obesity.